Evidence map›Paper›PMID 20091778›Full record

ArticleThe Laryngoscope2010

Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system.

Richard G Lee, Mark A Vecchiotti, John Heaphy, Ashok Panneerselvam, Mark D Schluchter, Nancy L Oleinick, Pierre Lavertu, Kumar N Alagramam, James E Arnold, Robert C Sprecher

Open access · greenAbstract read
In one paragraph

Article in The Laryngoscope, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management.Advances in experimental medicine and biology · 2021
    Article
  3. Review
  4. Recurrent respiratory papillomatosis: current and future perspectives.Therapeutics and clinical risk management · 2015
    Review
  5. Article
  6. Recurrent respiratory papillomatosis.Otolaryngologic clinics of North America · 2012
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Richard G LeeDepartment of Otolaryngology, Head and Neck Surgery, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Mark A Vecchiotti
John Heaphy
Ashok Panneerselvam
Mark D Schluchter
Nancy L Oleinick
Pierre Lavertu
Kumar N Alagramam
James E Arnold
Robert C Sprecher
Case Western Reserve University · US

Funding

SYNTHESIS OF PHTHALOCYANINES FOR TUMOR PHOTOTHERAPYP01CA048735 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SIBATA, CLAUDIO H · 1990 to 2002
$3.3M
Cardiolipin in Photodynamic TherapyR01CA106491 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI OLEINICK, NANCY L · 2005 to 2008
$972k
NCI NIH HHS P01 CA048735NCI NIH HHS P01CA48735NCI NIH HHS R01 CA106491
6 · The paper itself

Abstract

objectives/hypothesisTo evaluate the efficacy of photodynamic therapy (PDT) with the phthalocyanine photosensitizer Pc 4 for treating an animal model of recurrent respiratory papillomatosis (RRP).

methodsRabbit skin was grafted onto the dorsum of severe combined immunodeficient mice, two xenografts per animal. After the graft healed, it was inoculated with cottontail rabbit papillomavirus (CRPV). When papillomas developed, Pc 4 (0.6 or 1.0 mg/kg) was administered systemically, and 48 hours later, one papilloma of the two on each animal was exposed to 675-nm photoactivating light at either 100 or 150 J/cm(2). In addition to the contralateral tumors, which received Pc 4 but no light, other controls included animals receiving light only or neither agent. Response was assessed by measuring papilloma size with a caliper. Some papillomas and residual skin were harvested for histological assessment.

resultsFor the lower-dose PDT regimens, papilloma growth rates were not significantly different from the controls. In contrast, 13 of 15 papillomas receiving the higher Pc 4 dose (1.0 mg/kg) and the higher light fluence (150 J/cm(2)) regressed completely and did not regrow within the observation period of up to 79 days. The response of these papillomas was significantly different from the controls (P < .001). Histological analysis confirmed the absence of residual tumor following complete response and replacement with near-normal epithelium.

conclusionsPc 4-PDT is highly effective in treating virally induced (CRPV) papillomas in a murine model of RRP, and thus warrants further study as a treatment for HPV-induced papillomas.

Indexed as

AnimalsCottontail rabbit papillomavirusIndolesMiceMice, SCIDPapillomaPhotochemotherapyPhotosensitizing AgentsRabbitsSkin NeoplasmsSkin TransplantationTransplantation, HeterologousIndolesPhotosensitizing Agentsphthalocyanine Pc 4

Identifiers

PMID20091778
PMCPMC4459584
OpenAlexW2075169259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.